{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:23:55Z","timestamp":1787639035417,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Severe COVID-19 disease is characterised by a state of hyperinflammation. As key producers of inflammatory mediators in blood, altered inflammatory activity of monocytes within some individuals may contribute to adverse disease outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Analysis of monocyte activity under settings of infection and inflammation can be challenged by activation-induced shedding of monocyte receptors traditionally used to identify monocyte subsets. Here, we utilised alternative, more robust immunophenotyping approaches to investigate the impact of COVID-19 infection on monocyte phenotype and inflammatory status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Immunophenotype analysis of cryopreserved peripheral blood mononuclear cells from unvaccinated, previously COVID-19 naive individuals (median age 43 years, range 21-95, n=42) with a  PCR-confirmed acute COVID-19 infection indicated expansion of a novel population of CD14\n                      <jats:sub>low<\/jats:sub>\n                      CD16-  monocytes  as compared to control individuals (adjusted p value &amp;lt;0.001) which was more pronounced in individuals with severe disease presentation (p=0.004 for mild vs severe disease). Expansion of this population during acute COVID-19 was confirmed using an alternative, CD14 and CD16-independent strategy for identifying monocyte subsets and was termed infection associated monocytes (IAM). IAM were refractory to ex vivo stimulation with lipopolysaccharide (LPS) and their proportion correlated with plasma levels of TNF and CXCL10 (p&amp;lt;0.05 for both). Monocyte subsets from individuals with acute COVID-19 exhibited reduced basal and LPS-stimulated production of inflammatory cytokines including IL-1\u03b2, TNF and IL-6, indicative of an inert monocyte state. Expansion of IAM and impaired inflammatory activity persisted for up to 3 months after acute COVID-19 infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>COVID-19 is associated with expansion of a novel subset of monocytes with impaired inflammatory activity that persist for at least 3 months after acute infection. Whether this population is uniquely expanded by COVID-19, and the long term implications of its persistence post-acute disease, remain to be defined.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1814210","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:35:27Z","timestamp":1787636127000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Induction of dysfunctional CD14lowCD16- monocytes in acute COVID-19 infection"],"prefix":"10.3389","volume":"17","author":[{"given":"Salimeh","family":"Ebrahimnezhaddarzi","sequence":"first","affiliation":[{"name":"Disease Elimination Program, Burnet Institute","place":["Melbourne, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Altermatt","sequence":"additional","affiliation":[{"name":"Disease Elimination Program, Burnet Institute","place":["Melbourne, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Kek","sequence":"additional","affiliation":[{"name":"Disease Elimination Program, Burnet Institute","place":["Melbourne, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingling","family":"Zhou","sequence":"additional","affiliation":[{"name":"School of Health and Biomedical Sciences, RMIT University","place":["Melbourne, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Boo","sequence":"additional","affiliation":[{"name":"Disease Elimination Program, Burnet Institute","place":["Melbourne, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"McMahon","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Alfred Hospital and Monash University","place":["Melbourne, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Gardiner","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The Alfred Hospital and Monash University","place":["Melbourne, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Sacks-Davis","sequence":"additional","affiliation":[{"name":"Disease Elimination Program, Burnet Institute","place":["Melbourne, VIC, Australia"]},{"name":"School of Population Health and Preventive Medicine, Monash University","place":["Melbourne, VIC, Australia"]},{"name":"School of Population and Global Health, University of Melbourne","place":["Melbourne, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi E.","family":"Drummer","sequence":"additional","affiliation":[{"name":"Disease Elimination Program, Burnet Institute","place":["Melbourne, VIC, Australia"]},{"name":"Department of Microbiology and Immunology at The Peter Doherty Institute for Infection and Immunity, University of Melbourne","place":["Melbourne, VIC, Australia"]},{"name":"Department of Microbiology, Monash University","place":["Clayton, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Jaworowski","sequence":"additional","affiliation":[{"name":"Disease Elimination Program, Burnet Institute","place":["Melbourne, VIC, Australia"]},{"name":"School of Health and Biomedical Sciences, RMIT University","place":["Melbourne, VIC, Australia"]},{"name":"Department of Infectious Diseases, The Alfred Hospital and Monash University","place":["Melbourne, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Hearps","sequence":"additional","affiliation":[{"name":"Disease Elimination Program, Burnet Institute","place":["Melbourne, VIC, Australia"]},{"name":"Department of Infectious Diseases, The Alfred Hospital and Monash University","place":["Melbourne, VIC, Australia"]},{"name":"Department of Infectious Diseases at The Peter Doherty Institute for Infection and Immunity, University of Melbourne","place":["Melbourne, VIC, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2025.101144","article-title":"Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review","volume":"6","author":"Morgenstern","year":"2025","journal-title":"Lancet Microbe"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1474-9726.2012.00851.x","article-title":"Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function","volume":"11","author":"Hearps","year":"2012","journal-title":"Aging Cell"},{"key":"B3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12979-022-00321-9","article-title":"Phenotypic and functional alterations of monocyte subsets with aging","volume":"19","author":"Cao","year":"2022","journal-title":"Immun Ageing"},{"key":"B4","doi-asserted-by":"publisher","first-page":"28186","DOI":"10.1038\/s41598-025-13883-7","article-title":"Elderly individuals exhibit dysregulated monocyte responses to viral immune complexes compared to adults and children","volume":"15","author":"Domitien Payet","year":"2025","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12979-023-00377-1","article-title":"Transcriptional characteristics and functional validation of three monocyte subsets during aging","volume":"20","author":"Wang","year":"2023","journal-title":"Immun Ageing"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2020.12.003","article-title":"The impact of ageing on monocytes and macrophages","volume":"230","author":"De Maeyer","year":"2021","journal-title":"Immunol Lett"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.145928","article-title":"Chronic HIV infection induces transcriptional and functional reprogramming of innate immune cells","volume":"6","author":"van der Heijden","year":"2021","journal-title":"JCI Insight"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-326355","article-title":"Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets","volume":"118","author":"Wong","year":"2011","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01070","article-title":"Human monocyte subset distinctions and function: insights from gene expression analysis","volume":"11","author":"Cormican","year":"2020","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02035","article-title":"Human monocyte subsets and phenotypes in major chronic inflammatory diseases","volume":"10","author":"Kapellos","year":"2019","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.580250","article-title":"A longitudinal study of immune cells in severe COVID-19 patients","volume":"11","author":"Payen","year":"2020","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00927-9","article-title":"Intermediate monocytes expansion and homing markers expression in COVID-19 patients associate with kidney dysfunction","volume":"23","author":"Dentone","year":"2023","journal-title":"Clin Exp Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/jlb.4hi0720-470r","article-title":"Frontline science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes","volume":"109","author":"Zhang","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","author":"Schulte-Schrepping","year":"2020","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24188","article-title":"Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection","volume":"97","author":"Gatti","year":"2020","journal-title":"Cytometry A"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202049163","article-title":"Increased B-cell activity with consumption of activated monocytes in severe COVID-19 patients","volume":"51","author":"Kos","year":"2021","journal-title":"Eur J Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"108697","DOI":"10.2139\/ssrn.3999042","article-title":"Viral load is associated with mitochondrial dysfunction and altered monocyte phenotype in acute severe SARS-CoV-2 infection","volume":"108","author":"Romao","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24249","article-title":"Monocyte HLA-DR measurement by flow cytometry in COVID-19 patients: an interim review","volume":"97","author":"Benlyamani","year":"2020","journal-title":"Cytometry A"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.560330","article-title":"Early phases of COVID-19 are characterized by a reduction in lymphocyte populations and the presence of atypical monocytes","volume":"11","author":"Lombardi","year":"2020","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.18632\/aging.202571","article-title":"Elevated frequencies of CD14(+)HLA-DR(lo\/neg) MDSCs in COVID-19 patients","volume":"13","author":"Xue","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"20254","DOI":"10.1038\/s41598-021-99705-y","article-title":"Dynamic alterations in monocyte numbers, subset frequencies and activation markers in acute and convalescent COVID-19 individuals","volume":"11","author":"Rajamanickam","year":"2021","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s13073-022-01137-4","article-title":"Epigenetic and transcriptomic reprogramming in monocytes of severe COVID-19 patients reflects alterations in myeloid differentiation and the influence of inflammatory cytokines","volume":"14","author":"Godoy-Tena","year":"2022","journal-title":"Genome Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-021-00690-1","article-title":"Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19","volume":"23","author":"You","year":"2021","journal-title":"Nat Cell Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/v16020197","article-title":"Epigenetic control of innate immunity: consequences of acute respiratory virus infection","volume":"16","author":"Lefkowitz","year":"2024","journal-title":"Viruses"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.154183","article-title":"Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19","volume":"7","author":"Brauns","year":"2022","journal-title":"JCI Insight"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01761","article-title":"A novel, five-marker alternative to CD16-CD14 gating to identify the three human monocyte subsets","volume":"10","author":"Ong","year":"2019","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/s2468-2667(21)00133-x","article-title":"Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study","volume":"6","author":"Lane","year":"2021","journal-title":"Lancet Public Health"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101703","article-title":"Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial","volume":"54","author":"McMahon","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.crimmu.2021.10.002","article-title":"Optimization of stimulation and staining conditions for intracellular cytokine staining (ICS) for determination of cytokine-producing T cells and monocytes","volume":"2","author":"Mandala","year":"2021","journal-title":"Curr Res Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Statist Soc"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/imm.12888","article-title":"Human dendritic cell subsets: an update","volume":"154","author":"Collin","year":"2018","journal-title":"Immunology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071663","article-title":"Extensive phenotype of human inflammatory monocyte-derived dendritic cells","volume":"10","author":"Coutant","year":"2021","journal-title":"Cells"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202149632","article-title":"Human dendritic cell subsets: an updated view of their ontogeny and functional specialization","volume":"52","author":"Segura","year":"2022","journal-title":"Eur J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.147.5.1567","article-title":"Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes","volume":"147","author":"Bazil","year":"1991","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01902","article-title":"ADAM17-mediated reduction in CD14(++)CD16(+) monocytes ex vivo and reduction in intermediate monocytes with immune paresis in acute pancreatitis and acute alcoholic hepatitis","volume":"10","author":"Waller","year":"2019","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211034065","article-title":"High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19","volume":"8","author":"Karawajczyk","year":"2021","journal-title":"Ther Adv Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309145","article-title":"Human blood monocyte subsets: a new gating strategy defined using cell surface markers identified by mass cytometry","volume":"37","author":"Thomas","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah4573","article-title":"Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors","volume":"356","author":"Villani","year":"2017","journal-title":"Science"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211191","article-title":"CD127 imprints functional heterogeneity to diversify monocyte responses in inflammatory diseases","volume":"219","author":"Zhang","year":"2022","journal-title":"J Exp Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2010.08.003","article-title":"CD56 negative NK cells: origin, function, and role in chronic viral disease","volume":"31","author":"Bjorkstrom","year":"2010","journal-title":"Trends Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.838132","article-title":"Multi-omics integration reveals only minor long-term molecular and functional sequelae in immune cells of individuals recovered from COVID-19","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.07.019","article-title":"Epigenetic memory of coronavirus infection in innate immune cells and their progenitors","volume":"186","author":"Cheong","year":"2023","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1710783","article-title":"Transcriptome analysis of classical blood cells reveals downregulation of pro-inflammatory genes in the classical monocytes of long COVID patients","volume":"16","author":"Fricke","year":"2025","journal-title":"Front Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2010.03.006","article-title":"Comparative in vitro stimulation with lipopolysaccharide to study TNFalpha gene expression in fresh whole blood, fresh and frozen peripheral blood mononuclear cells","volume":"357","author":"Chen","year":"2010","journal-title":"J Immunol Methods"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1814210\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:35:28Z","timestamp":1787636128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1814210\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2026.1814210"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1814210","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1814210"}}